Fintel reports that on April 8, 2025, William Blair initiated coverage of Ocular Therapeutix (NasdaqGM:OCUL) with a ...

In a report released today, Andy Hsieh from William Blair maintained a Buy rating on Skye Bioscience (SKYE – Research Report). The company’s ...

Healthcare Analysts, along with argenx ( ARGX) SE CEO Tim Van Hauwermeiren and Dr. Chafic Karam discuss Vyvgart on an Analyst/Industry conference call to be held on April 8 at 1 pm. Published first on ...

William Blair Large Cap Growth Fund earns an Average Process Pillar rating. The leading factor in the rating is the stability of the management team. Specifically, the fund has not seen a manager ...

In a report released today, Matt Larew from William Blair maintained a Buy rating on 908 Devices (MASS – Research Report). The company’s shares opened today at $4.43. Discover outperforming ...

In a report released today, Jon Andersen from William Blair maintained a Buy rating on Simply Good Foods (SMPL – Research Report). The ...

Investment analysts at William Blair issued their Q1 2025 earnings per share (EPS) estimates for shares of Rekor Systems in a ...